Related Experiment Video
Updated: Jun 17, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Coagulation protease-induced extracellular vesicles: their potential effects on coagulation and inflammation
Kaushik Das1, L Vijaya Mohan Rao2
1Biotechnology Research and Innovation Council-National Institute of Biomedical Genomics, Kalyani, West Bengal, India.
Coagulation proteases like factor VIIa release extracellular vesicles (EVs) that mediate intercellular communication. These EVs, rich in phosphatidylserine and microRNAs, impact hemostasis and may treat bleeding and inflammatory disorders.
Area of Science:
- Biochemistry
- Cell Biology
- Hematology
Background:
- Coagulation proteases activate protease-activated receptors (PARs), influencing cellular functions.
- PAR activation effects are cell-specific, but extracellular vesicles (EVs) mediate cross-talk between cell types.
- EVs are nanosized vesicles transferring bioactive molecules, enabling intercellular communication.
Purpose of the Study:
- To review how coagulation proteases, specifically factor VIIa (FVIIa), trigger EV release.
- To discuss the composition and function of FVIIa-released EVs.
- To explore the therapeutic potential of FVIIa-released EVs in bleeding and inflammatory conditions.
Main Methods:
- Review of existing literature on coagulation proteases, PARs, and EVs.
- Analysis of recent findings on FVIIa-induced EV release from vascular endothelium.
- Examination of EV cargo, including phosphatidylserine and microRNAs.
Main Results:
- FVIIa promotes EV release via endothelial cell protein C receptor-dependent PAR1 signaling.
- FVIIa-released EVs possess procoagulant and cytoprotective properties.
- These EVs are enriched with phosphatidylserine and anti-inflammatory microRNAs.
Conclusions:
- Coagulation proteases, particularly FVIIa, induce EV release that influences cellular responses and hemostasis.
- FVIIa-released EVs have therapeutic potential for treating bleeding and inflammatory disorders like hemophilic arthropathy.
More Related Videos
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...